These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39103439)

  • 1. The effect of hsCRP on TyG index-associated cardiovascular risk in patients with acute coronary syndrome undergoing PCI.
    Ma X; Chu H; Sun Y; Cheng Y; Zhang D; Zhou Y; Liu X; Wang Z
    Sci Rep; 2024 Aug; 14(1):18083. PubMed ID: 39103439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined effect of triglyceride-glucose index and high-sensitivity C-reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study.
    Li Q; Song Y; Zhang Z; Xu J; Liu Z; Tang X; Wang X; Chen Y; Zhang Y; Zhu P; Guo X; Jiang L; Wang Z; Liu R; Wang Q; Yao Y; Feng Y; Han Y; Yuan J
    J Diabetes; 2024 Aug; 16(8):e13589. PubMed ID: 39136595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome.
    Wang C; Liao P; Tang C; Chen C; Zhang X
    Front Endocrinol (Lausanne); 2024; 15():1423227. PubMed ID: 39257901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
    Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
    Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L; Wang Y; Wang W; Wang Z
    Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of triglyceride-glucose index in improving the prediction of post-percutaneous coronary intervention clinical outcomes: a systematic review and meta-analysis.
    Kohar K; Sanjaya IS; Amirah S; Yumnanisha DA; Ambari AM
    Acta Cardiol; 2024 Jul; 79(5):557-565. PubMed ID: 38722072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.
    Pang S; Miao G; Zhou Y; Du Y; Rui Z; Zhao X
    Front Cardiovasc Med; 2022; 9():957626. PubMed ID: 36093151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
    Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of TyG Index and GRACE Risk Score as Long-Term Prognostic Marker in Patients with ACS Complicated with T2DM Undergoing PCI.
    Qin Z; Xu S; Yuan R; Wang Z; Lu Y; Xu Y; Lv Y; Yu F; Bai J; Zhang H; Zhang L; Zhang J; Tang J
    Diabetes Metab Syndr Obes; 2022; 15():3015-3025. PubMed ID: 36196143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
    Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
    Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
    Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of the Triglyceride-Glucose Index in Forecasting Ten-Year Major Adverse Cardiovascular Events in Non-Diabetic Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Köktürk U; Onalan O; Somuncu MU; Uygur B; Erbay İ; Çakan F; Avcı A
    Turk Kardiyol Dern Ars; 2024 Jun; 52(4):253-259. PubMed ID: 38829642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention.
    Sun T; Huang X; Zhang B; Ma M; Chen Z; Zhao Z; Zhou Y
    Front Endocrinol (Lausanne); 2023; 14():1100399. PubMed ID: 36814584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3184-3192. PubMed ID: 34511291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.